RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Integra Lifesciences Holdings - Stock

Integra Lifesciences Holdings ROCE 2024

Integra Lifesciences Holdings ROCE

0.17

Ticker

IART

ISIN

US4579852082

WKN

897013

In 2024, Integra Lifesciences Holdings's return on capital employed (ROCE) was 0.17, a 5.37% increase from the 0.16 ROCE in the previous year.

Integra Lifesciences Holdings Aktienanalyse

What does Integra Lifesciences Holdings do?

Integra Lifesciences Holdings Corp is a multinational manufacturer and provider of medical devices, implants, and instruments. The company is headquartered in Plainsboro, New Jersey and was founded in 1989. Integra Lifesciences specializes in the development and marketing of products for orthopedic surgery, neurosurgery, and plastic and reconstructive surgery. The company has a wide range of products that have been constantly improved and expanded over the years. The history of Integra Lifesciences is characterized by continuous expansion through the acquisition of other companies. In 1996, the company acquired Confluent Surgical, which allowed them to enter the tissue adhesive sector. In the following years, several companies were acquired, including Depuy Orthopaedics, Kaye Surgical, and SeaSpine Holdings. Each acquisition has contributed to Integra Lifesciences being able to offer its customers an extensive product portfolio that meets all requirements. Integra Lifesciences has a diversified business model that focuses on four different divisions: anesthesia, neurosurgery, plastic and reconstructive surgery, and orthopedic surgery. Each division has its own range of products that are tailored to the specific requirements of its customers. Integra Lifesciences supplies high-quality medical instruments that are valued by surgeons around the world. These include products such as bone cement, implants, skull plates, bone screws, tissue adhesives, and spinal fusion devices. All products from Integra Lifesciences aim to improve patient care and enhance patients' quality of life. The anesthesia division offers a wide range of products and technologies that improve the administration of anesthesia and enable optimal patient care. In addition to traditional products such as anesthesia masks and tubes, Integra Lifesciences also develops innovative products such as disposable ventilation systems that can increase safety and efficiency. The neurosurgery division offers a wide range of devices and implants for the treatment of brain and spinal cord conditions. The product range includes skull plates, bone connectors, and devices for performing brain surgeries. In the plastic and reconstructive surgery division, Integra Lifesciences offers products for the treatment of burns and the reconstruction of bones and soft tissues. The company has a wide range of products, including skin grafts, scar treatment, and liposuction. Orthopedic surgery is one of the established divisions at Integra Lifesciences, offering a wide range of products for the treatment of bone and joint problems. The company provides implants and instruments for all types of orthopedic procedures, including hip and knee replacements, spinal fusion, and limb reconstruction. Overall, Integra Lifesciences Holdings Corp is a leading manufacturer of medical devices, implants, and instruments specializing in the fields of orthopedics, neurosurgery, and plastic and reconstructive surgery. With its comprehensive product range and innovative technologies, Integra Lifesciences has gained a leading position in the industry, providing its customers worldwide with the highest quality and safety. Integra Lifesciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Integra Lifesciences Holdings's Return on Capital Employed (ROCE)

Integra Lifesciences Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Integra Lifesciences Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Integra Lifesciences Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Integra Lifesciences Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Integra Lifesciences Holdings stock

What is the ROCE (Return on Capital Employed) of Integra Lifesciences Holdings this year?

The ROCE of Integra Lifesciences Holdings is 0.17 undefined this year.

How has the ROCE (Return on Capital Employed) of Integra Lifesciences Holdings developed compared to the previous year?

The ROCE of Integra Lifesciences Holdings has increased by 5.37% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Integra Lifesciences Holdings?

A high Return on Capital Employed (ROCE) indicates that Integra Lifesciences Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Integra Lifesciences Holdings?

A low ROCE (Return on Capital Employed) can indicate that Integra Lifesciences Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Integra Lifesciences Holdings impact the company?

An increase in the ROCE of Integra Lifesciences Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Integra Lifesciences Holdings affect the company?

A decrease in ROCE of Integra Lifesciences Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Integra Lifesciences Holdings?

Some factors that can affect Integra Lifesciences Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Integra Lifesciences Holdings so important for investors?

The ROCE of Integra Lifesciences Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Integra Lifesciences Holdings take to improve the ROCE?

To improve the ROCE, Integra Lifesciences Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Integra Lifesciences Holdings pay?

Over the past 12 months, Integra Lifesciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Integra Lifesciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Integra Lifesciences Holdings?

The current dividend yield of Integra Lifesciences Holdings is .

When does Integra Lifesciences Holdings pay dividends?

Integra Lifesciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Integra Lifesciences Holdings?

Integra Lifesciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Integra Lifesciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Integra Lifesciences Holdings located?

Integra Lifesciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integra Lifesciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integra Lifesciences Holdings from 7/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did Integra Lifesciences Holdings pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of Integra Lifesciences Holdings in the year 2023?

In the year 2023, Integra Lifesciences Holdings distributed 0 USD as dividends.

In which currency does Integra Lifesciences Holdings pay out the dividend?

The dividends of Integra Lifesciences Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integra Lifesciences Holdings

Our stock analysis for Integra Lifesciences Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integra Lifesciences Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.